Method of treating bendamustine-responsive conditions in patients requiring reduced volumes for administration | Patent Number 09000021

US 09000021 B2
Application Number13838267
Publication NumberUS 20130253026 A1
Pendency2 years, 23 days
Filled DateMar 15, 2013
Priority DateMar 20, 2012
Publication DateSep 26, 2013
Expiration DateMar 19, 2032
Inventor/ApplicantsScott L. Tarriff
Srikanth Sundaram
ExaminesCLAYTOR, DEIRDRE RENEE
Art Unit1627
Technology Center1600
Assignments
Jpmorgan Chase Bank
Current
Eagle Pharmaceuticals Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.